Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc.（CPRX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cprx · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Buy
16 位分析师
共识
评级分布
12 个月目标价
High
$32.00
Consensus
$31.75
+1.5% upside
Low
$31.50
Median: $31.75 · Last Close: $31.27
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$31.75
1.5% upside
High Target
$32
2.3%
Low Target
$31.5
0.7%
Current Price
$31.27
as of today
Based on analyst price targets, the CPRX stock price prediction for the next 12 months ranges from $31.5 to $32. The consensus CPRX price forecast of $31.75 implies 1.5% upside from the current price of $31.27.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $31.27 | ↑ 0.01% |
1-day model range: $31.16–$31.39. Peak: $31.39 (+0.01%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $46 | +48.4% |
| 2028 | $60 | +91.6% |
| 2029 | $70 | +125.0% |
| 2030 | $78 | +148.6% |
| 2031 | — | +164.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CPRX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-05-08 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2026-05-07 | Stephens & Co. | Downgrade ↓ | Overweight→Equal Weight |
| 2026-03-03 | Citigroup | Maintains | Buy→Buy |
| 2025-11-07 | Citigroup | Maintains | Buy→Buy |
| 2025-03-03 | Baird | Maintains | Outperform→Outperform |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-27 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-09 | B of A Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Catalyst Pharmaceuticals, Inc. (CPRX) stock. Of the recent 61 rating actions, 3 were upgrades and 6 were downgrades. 16 analysts currently cover CPRX.
分析师推荐趋势
CPRX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$633M
↓ 17.4% YoY
Revenue Next Year
$703M
↑ 11.1% YoY
EPS This Year
$1.92
EPS Next Year
$2.24
↑ 16.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CPRX EPS of $1.92 for the current fiscal year, based on estimates from 3 analysts. The CPRX revenue forecast is $633M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CPRX 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CPRX 的共识目标价为 $31.75（+1.5% 上行空间），分析师共识为 Buy。
CPRX 的短期预测（明日）为 $31.27（+0.01%）。 CPRX 对 2027 年的股价预测均值为 $46。 CPRX 对 2030 年的预测区间为 $75–$81。
Catalyst Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 CPRX。CPRX 在 2027 年的整体展望偏积极，在覆盖分析师中约 75% 对应 Buy 共识。
常见问题
CPRX 预测 · 8 个问题根据 16 位华尔街分析师，CPRX 的 12 个月平均目标价为 $31.75，最高 $32.00、最低 $31.50。若有图表，中位目标价可在上方查看。相对当前价 $31.27，隐含约 +1.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.